Ngā hua rapu - Sermet‐Gaudelus, Isabelle

Whakamahine hua
  1. 1
    Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine

    Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine mā Pranke, Iwona, Golec, Anita, Hinzpeter, Alexandre, Edelman, Aleksander, Sermet-Gaudelus, Isabelle

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Airway Surface Liquid pH Regulation in Airway Epithelium Current Understandings and Gaps in Knowledge

    Airway Surface Liquid pH Regulation in Airway Epithelium Current Understandings and Gaps in Knowledge mā Zajac, Miroslaw, Dreano, Elise, Edwards, Aurelie, Planelles, Gabrielle, Sermet-Gaudelus, Isabelle

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis

    Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis mā Marsac, Charlotte, Berdah, Laura, Thouvenin, Guillaume, Sermet-Gaudelus, Isabelle, Corvol, Harriet

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators

    Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators mā Sermet-Gaudelus, Isabelle, Nguyen-Khoa, Thao, Hatton, Aurélie, Hayes, Kate, Pranke, Iwona

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice

    Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice mā Saussereau, Emilie Lyne, Roussel, Delphine, Diallo, Siradiou, Debarbieux, Laurent, Edelman, Aleksander, Sermet-Gaudelus, Isabelle

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Use of 16S rRNA Gene Sequencing for Identification of Nonfermenting Gram-Negative Bacilli Recovered from Patients Attending a Single Cystic Fibrosis Center

    Use of 16S rRNA Gene Sequencing for Identification of Nonfermenting Gram-Negative Bacilli Recovered from Patients Attending a Single Cystic Fibrosis Center mā Ferroni, Agnes, Sermet-Gaudelus, Isabelle, Abachin, Eric, Quesne, Gilles, Lenoir, Gerard, Berche, Patrick, Gaillard, Jean-Louis

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients

    Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients mā Ollero, Mario, Astarita, Giuseppe, Guerrera, Ida Chiara, Sermet-Gaudelus, Isabelle, Trudel, Stéphanie, Piomelli, Daniele, Edelman, Aleksander

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Determinants of Refusal of A/H1N1 Pandemic Vaccination in a High Risk Population: A Qualitative Approach

    Determinants of Refusal of A/H1N1 Pandemic Vaccination in a High Risk Population: A Qualitative Approach mā d'Alessandro, Eugenie, Hubert, Dominique, Launay, Odile, Bassinet, Laurence, Lortholary, Olivier, Jaffre, Yannick, Sermet-Gaudelus, Isabelle

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    A multiple reader scoring system for Nasal Potential Difference parameters

    A multiple reader scoring system for Nasal Potential Difference parameters mā Solomon, George M., Liu, Bo, Sermet-Gaudelus, Isabelle, Fajac, Isabelle, Wilschanski, Michael, Vermeulen, Francois, Rowe, Steven M.

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD)

    Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD) mā Solomon, George M., Bronsveld, Inez, Hayes, Kathryn, Wilschanski, Michael, Melotti, Paola, Rowe, Steven M., Sermet-Gaudelus, Isabelle

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    The CF-CIRC study: a French collaborative study to assess the accuracy of Cystic Fibrosis diagnosis in neonatal screening

    The CF-CIRC study: a French collaborative study to assess the accuracy of Cystic Fibrosis diagnosis in neonatal screening mā Sermet-Gaudelus, Isabelle, Roussel, Delphine, Bui, Stéphanie, Deneuville, Eric, Huet, Frédéric, Reix, Philippe, Bellon, Gabriel, Lenoir, Gérard, Edelman, Aleksander

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Impact of COVID-19 on people with cystic fibrosis

    Impact of COVID-19 on people with cystic fibrosis mā Colombo, Carla, Burgel, Pierre-Régis, Gartner, Silvia, van Koningsbruggen-Rietschel, Silke, Naehrlich, Lutz, Sermet-Gaudelus, Isabelle, Southern, Kevin W

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Myeloperoxidase Promoter Polymorphism −463G Is Associated With More Severe Clinical Expression of Cystic Fibrosis Pulmonary Disease

    Myeloperoxidase Promoter Polymorphism −463G Is Associated With More Severe Clinical Expression of Cystic Fibrosis Pulmonary Disease mā Reynolds, Wanda F., Sermet-Gaudelus, Isabelle, Gausson, Valérie, Feuillet, Marie-Noëlle, Bonnefont, Jean-Paul, Lenoir, Gérard, Descamps-Latscha, Béatrice, Witko-Sarsat, Véronique

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Clonal Relationship and Differentiation among Mycobacterium abscessus Isolates as Determined Using the Semiautomated Repetitive Extragenic Palindromic Sequence PCR-Based DiversiLab System

    Clonal Relationship and Differentiation among Mycobacterium abscessus Isolates as Determined Using the Semiautomated Repetitive Extragenic Palindromic Sequence PCR-Based DiversiLab... mā Mougari, Faiza, Raskine, Laurent, Ferroni, Agnes, Marcon, Estelle, Sermet-Gaudelus, Isabelle, Veziris, Nicolas, Heym, Beate, Gaillard, Jean-Louis, Nassif, Xavier, Cambau, Emmanuelle

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Nonfermenting Gram-Negative Bacilli Isolated from Cystic Fibrosis Patients

    Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Nonfermenting Gram-Negative Bacilli Isolated from Cystic Fibrosis Patients mā Degand, Nicolas, Carbonnelle, Etienne, Dauphin, Brunhilde, Beretti, Jean-Luc, Le Bourgeois, Muriel, Sermet-Gaudelus, Isabelle, Segonds, Christine, Berche, Patrick, Nassif, Xavier, Ferroni, Agnès

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    A Novel Lipidomic Strategy Reveals Plasma Phospholipid Signatures Associated with Respiratory Disease Severity in Cystic Fibrosis Patients

    A Novel Lipidomic Strategy Reveals Plasma Phospholipid Signatures Associated with Respiratory Disease Severity in Cystic Fibrosis Patients mā Guerrera, Ida Chiara, Astarita, Giuseppe, Jais, Jean-Philippe, Sands, Dorota, Nowakowska, Anna, Colas, Julien, Sermet-Gaudelus, Isabelle, Schuerenberg, Martin, Piomelli, Daniele, Edelman, Aleksander, Ollero, Mario

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Urinary Exosomes of Patients with Cystic Fibrosis Unravel CFTR-Related Renal Disease

    Urinary Exosomes of Patients with Cystic Fibrosis Unravel CFTR-Related Renal Disease mā Gauthier, Sebastien, Pranke, Iwona, Jung, Vincent, Martignetti, Loredana, Stoven, Véronique, Nguyen-Khoa, Thao, Semeraro, Michaela, Hinzpeter, Alexandre, Edelman, Aleksander, Guerrera, Ida Chiara, Sermet-Gaudelus, Isabelle

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Value of the Chlorhexidine Decontamination Method for Recovery of Nontuberculous Mycobacteria from Sputum Samples of Patients with Cystic Fibrosis

    Value of the Chlorhexidine Decontamination Method for Recovery of Nontuberculous Mycobacteria from Sputum Samples of Patients with Cystic Fibrosis mā Ferroni, Agnès, Vu-Thien, Hoang, Lanotte, Philippe, Le Bourgeois, Muriel, Sermet-Gaudelus, Isabelle, Fauroux, Brigitte, Marchand, Sophie, Varaigne, Françoise, Berche, Patrick, Gaillard, Jean-Louis, Offredo, Catherine

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pathway

    Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pat... mā Saint-Criq, Vinciane, Villeret, Bérengère, Bastaert, Fabien, Kheir, Saadé, Hatton, Aurélie, Cazes, Aurélie, Xing, Zhou, Sermet-Gaudelus, Isabelle, Garcia-Verdugo, Ignacio, Edelman, Aleksander, Sallenave, Jean-Michel

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis

    Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis mā Hanafin, Patrick O., Sermet-Gaudelus, Isabelle, Griese, Matthias, Kappler, Matthias, Ellemunter, Helmut, Schwarz, Carsten, Wilson, John, Tan, Marsha, Velkov, Tony, Rao, Gauri G., Schneider-Futschik, Elena K.

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: